Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke.

Santamato A, Panza F, Ranieri M, Frisardi V, Micello MF, Filoni S, Fortunato F, Intiso D, Basciani M, Logroscino G, Fiore P.

J Neural Transm (Vienna). 2013 Mar;120(3):469-76. doi: 10.1007/s00702-012-0892-x.

PMID:
22955957
2.

Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.

Santamato A, Micello MF, Panza F, Fortunato F, Pilotto A, Giustini A, Testa A, Fiore P, Ranieri M, Spidalieri R.

Eur J Phys Rehabil Med. 2013 Aug;49(4):483-9.

3.

Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.

Kaňovský P, Slawek J, Denes Z, Platz T, Comes G, Grafe S, Pulte I.

J Rehabil Med. 2011 May;43(6):486-92. doi: 10.2340/16501977-0796.

4.

Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke.

Santamato A, Micello MF, Ranieri M, Valeno G, Albano A, Baricich A, Cisari C, Intiso D, Pilotto A, Logroscino G, Panza F.

J Neurol Sci. 2015 Mar 15;350(1-2):1-6. doi: 10.1016/j.jns.2015.01.033. Review.

PMID:
25684341
5.

Treatment of upper limb spasticity after stroke: one-year safety and efficacy of botulinum toxin type A NT201.

Fiore P, Santamato A, Ranieri M, Bellomo RG, Saggini R, Panza F, Megna G, Cristella G, Megna M.

Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1 Suppl):57S-62S.

PMID:
22652163
6.

Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.

Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.

Arch Phys Med Rehabil. 2008 May;89(5):799-806. doi: 10.1016/j.apmr.2008.01.007.

PMID:
18452724
7.

Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.

Lukban MB, Rosales RL, Dressler D.

J Neural Transm (Vienna). 2009 Mar;116(3):319-31. doi: 10.1007/s00702-008-0175-8. Review.

PMID:
19142573
8.

Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.

Santamato A, Micello MF, Panza F, Fortunato F, Baricich A, Cisari C, Pilotto A, Logroscino G, Fiore P, Ranieri M.

J Neurol Sci. 2014 Dec 15;347(1-2):39-43. doi: 10.1016/j.jns.2014.09.016.

PMID:
25263601
9.

Botulinum toxin type A in post-stroke upper limb spasticity.

Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M; GSK1358820 Spasticity Study Group..

Curr Med Res Opin. 2010 Aug;26(8):1983-92. doi: 10.1185/03007995.2010.497103.

PMID:
20569068
10.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.

Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L.

Eur J Neurol. 2001 Nov;8(6):559-65.

PMID:
11784339
12.
13.

Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.

Baguley IJ, Nott MT, Turner-Stokes L, De Graaff S, Katrak P, McCrory P, de Abadal M, Hughes A.

J Rehabil Med. 2011 Nov;43(11):1032-7. doi: 10.2340/16501977-0885.

14.

Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.

Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C; Botox Post-Stroke Spasticity Study Group..

N Engl J Med. 2002 Aug 8;347(6):395-400.

15.

A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.

Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J, Benecke R, Collin C, Muller F, Ward CD, Neumann C.

Stroke. 2000 Oct;31(10):2402-6.

16.

Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.

Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M; GSK1358820 Spasticity Study Group..

J Neurol. 2010 Aug;257(8):1330-7. doi: 10.1007/s00415-010-5526-3. Erratum in: J Neurol. 2010 Aug;257(8):1416.

17.

How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.

Pennati GV, Da Re C, Messineo I, Bonaiuti D.

Eur J Phys Rehabil Med. 2015 Aug;51(4):381-7.

18.

Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.

Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS.

Neurorehabil Neural Repair. 2012 Sep;26(7):812-21. doi: 10.1177/1545968311430824.

PMID:
22371239
19.

Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.

Gracies JM, Brashear A, Jech R, McAllister P, Banach M, Valkovic P, Walker H, Marciniak C, Deltombe T, Skoromets A, Khatkova S, Edgley S, Gul F, Catus F, De Fer BB, Vilain C, Picaut P; International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group..

Lancet Neurol. 2015 Oct;14(10):992-1001. doi: 10.1016/S1474-4422(15)00216-1.

PMID:
26318836
20.

Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.

Cardoso E, Rodrigues B, Lucena R, Oliveira IR, Pedreira G, Melo A.

Arq Neuropsiquiatr. 2005 Mar;63(1):30-3.

Supplemental Content

Support Center